Astrocyte Pharmaceuticals Completes $2.3M Pre-A Financing Round
Cambridge, MA, June 6, 2018 – Astrocyte Pharmaceuticals Inc. announced today that it has completed a Pre-A financing round that raised over $2.3M. The company is advancing several small molecule neuroprotective therapeutics for the treatment of stroke, traumatic brain injury (TBI) or concussion, and neurodegenerative disease. The Pre-A round was led by Kaitai Capital, and […]
Astrocyte Pharmaceuticals Completes $2.3M Pre-A Financing Round Read More »
